New York—The incidence of esophageal adenocarcinoma is expected to rise over the next five to 10 years, as mortality associated with the condition is largely due to the fact that many patients present late, when options are few and survival is poor.
Nicholas Shaheen, MD
But steps that clinicians can—or don’t—take also matter, such as the underuse of biopsy in surveillance endoscopy. In a discussion following his presentation on Barrett’s esophagus (BE) at the 2015